BioAffinity Technologies extends gains after stellar Nasdaq debut
02/09/2022 15:48
** Cancer diagnostic developer bioAffinity Technologies Inc
shares BIAF.O jump 19% to $9.90, a day after soaring ~36% on
their Nasdaq market debut
** Co priced its initial public offering of nearly 1.3
million units of common stock and warrants at $6.12/ unit to
raise over $7.8 mln urn:newsml:reuters.com:*:nBwMVbjVa
** Co aims to utilize the net proceeds for the
commercialization of its non-invasive test for the early
detection of lung cancer
(Reporting by Pratik Jain)
((Pratik.Jain@thomsonreuters.com;))